(Q34152867)

31 July 2017

title

Angiotensin II-stimulated secretion of arginine vasopressin is inhibited by atrial natriuretic peptide in humans (English)

1 reference

atrial natriuretic peptide

31 July 2017

0 references

0 references

author name string

Toshiyoshi Matsukawa

series ordinal

1

1 reference

31 July 2017

Takenori Miyamoto

series ordinal

2

1 reference

31 July 2017

publication date

1 December 2010

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

31 July 2017

published in

1 reference

31 July 2017

volume

300

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

R624-9

1 reference

Role of the renin-angiotensin system in the control of vasopressin secretion in conscious dogs

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

In vitro evidence for an inhibitory effect of atrial natriuretic peptide on vasopressin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Physiology and pathophysiology of atrial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

alpha-ANP alters reflex control of lumbar and renal sympathetic nerve activity and heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Atrial natriuretic hormone inhibits angiotensin II-stimulated sympathetic nerve activity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Effects of angiotensin II on arginine-vasopressin in physiological and pathological situations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

21 January 2018

Angiotensin in the Brain

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Central nervous system actions of atrial natriuretic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Osmotic and nonosmotic control of vasopressin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Angiotensin stimulated AVP-release in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Atrial natriuretic peptide inhibits postural release of renin and vasopressin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00324.2010

10.1152/AJPREGU.00324.2010

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference